|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.125 EUR | -3.63% |
|
-16.17% | -18.89% |
| 06-11 | Transcript : Innate Pharma S.A. - Special Call | |
| 06-04 | Innate Pharma: positive data in mycosis fungoides | CF |
PRESS RELEASE
HALF-YEAR REPORT ON INNATE PHARMA'S LIQUIDITY CONTRACT WITH NATIXIS SECURITIES Marseilles, France, January 2, 2012Under the liquidity contract entrusted by Innate Pharma to Natixis Securities, the following assets appeared on the liquidity account as at December 31, 2011:
| 1st Jan change | Capi. | |
|---|---|---|
| -18.89% | 184M | |
| +40.80% | 53.67B | |
| +35.79% | 38.86B | |
| -8.05% | 38.76B | |
| -8.98% | 27.27B | |
| +10.69% | 25.91B | |
| -16.21% | 20.29B | |
| +31.00% | 12.78B | |
| +28.51% | 12.18B | |
| -1.67% | 11.96B |
INNATE PHARMA 
By 